Paraneoplastic cerebellar degeneration associated with cerebellar hypermetabolism: Case report
- PMID: 29901574
- PMCID: PMC6024112
- DOI: 10.1097/MD.0000000000010717
Paraneoplastic cerebellar degeneration associated with cerebellar hypermetabolism: Case report
Abstract
Rationale: Paraneoplastic cerebellar degeneration (PCD) is an immune-mediated neurological deficit affecting the cerebellum. Anti-Yo antibody positive PCD is a rare occurrence most likely associated with gynecologic or breast malignancies. The identification of the underlying tumor is a diagnostic challenge in many of these patients.
Patient concerns: We present a 68-year-old woman with acute symptoms of PCD as a first sign of underlying occult malignancy. Further investigation revealed a positive anti-Yo antibody. Although brain magnetic resonance imaging (MRI) was unremarkable, positron emission tomography (PET)/computed tomography (CT) revealed intense hypermetabolism of cerebellum and diffused hypometabolism in the rest of brain. On 1-year follow-up, despite the primary malignancy is still unknown, her symptoms improved significantly after immunotherapy.
Diagnoses: Paraneoplastic cerebellar degeneration.
Interventions: The patient was given IV methylprednisolone 500 mg once a day for 5 consecutive days, followed by oral prednisone 60 mg once a day for 3 months.
Outcomes: The patient's symptoms were gradually improved during the hospitalization period. On one year follow up, she was able to walk independently and perform some simple tasks.
Lessons: Cerebellar hypermetabolism in PCD suspected patients may help confirming the diagnosis in an earlier stage and may predict a better outcome after immunotherapy.
Conflict of interest statement
The authors declare no financial or other conflicts of interest.
Figures



Similar articles
-
Paraneoplastic cerebellar degeneration as the first evidence of malignancy: a case report.J Obstet Gynaecol Res. 2014 May;40(5):1463-5. doi: 10.1111/jog.12331. Epub 2014 Apr 2. J Obstet Gynaecol Res. 2014. PMID: 24689522
-
Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration associated with cognitive affective syndrome in a patient with breast cancer: a case report and literature review.Curr Oncol. 2018 Dec;25(6):e585-e591. doi: 10.3747/co.25.4106. Epub 2018 Dec 1. Curr Oncol. 2018. PMID: 30607127 Free PMC article. Review.
-
Paraneoplastic cerebellar degeneration with anti-Yo antibodies and an associated submandibular gland tumor: a case report.BMC Neurol. 2022 May 2;22(1):165. doi: 10.1186/s12883-022-02684-4. BMC Neurol. 2022. PMID: 35501715 Free PMC article.
-
[A case of slowly progressive anti-Yo-associated paraneoplastic cerebellar degeneration successfully treated with antitumor and immunotherapy].Rinsho Shinkeigaku. 2016 Jul 28;56(7):477-80. doi: 10.5692/clinicalneurol.cn-000872. Epub 2016 Jun 30. Rinsho Shinkeigaku. 2016. PMID: 27356731 Japanese.
-
Immunological Bases of Paraneoplastic Cerebellar Degeneration and Therapeutic Implications.Front Immunol. 2020 Jun 2;11:991. doi: 10.3389/fimmu.2020.00991. eCollection 2020. Front Immunol. 2020. PMID: 32655545 Free PMC article. Review.
Cited by
-
Evaluation of the Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes in China.Front Immunol. 2022 Jan 31;13:790400. doi: 10.3389/fimmu.2022.790400. eCollection 2022. Front Immunol. 2022. PMID: 35173717 Free PMC article.
-
Combination of structural MRI, functional MRI and brain PET-CT provide more diagnostic and prognostic value in patients of cerebellar ataxia associated with anti-Tr/DNER: a case report.BMC Neurol. 2021 Sep 24;21(1):368. doi: 10.1186/s12883-021-02403-5. BMC Neurol. 2021. PMID: 34560837 Free PMC article.
-
Paraneoplastic cerebellar degeneration combined with Lambert-Eaton myasthenia gravis syndrome in a patient positive for SOX1 antibody.Am J Transl Res. 2025 Apr 15;17(4):3001-3008. doi: 10.62347/NHTJ8584. eCollection 2025. Am J Transl Res. 2025. PMID: 40385046 Free PMC article.
References
-
- Peterson K, Rosenblum MK, Kotanides H, et al. Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology 1992;42:1931–7. - PubMed
-
- Shams’ili S, Grefkens J, de Leeuw B, et al. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain 2003;126:1409–18. - PubMed
-
- Lorusso L, Hart IK, Giometto B, et al. Immunological features of neurological paraneoplastic syndromes. Int J Immunopathol Pharmacol 2004;17:135–44. - PubMed
-
- Rojas I, Graus F, Keime-Guibert F, et al. Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies. Neurology 2000;55:713–5. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources